Maris Research

Future US climate proposals depend on makeup of Senate in 2021, but compromises possible

Share on facebook
Share on facebook
Share on twitter
Share on linkedin

Former Vice President Joe Biden has prioritized climate policy in his platform for the upcoming US Presidential Election, but the future composition of the Senate would have a big influence on how a potential Biden administration pursues energy and emissions goals.

As discussed in the recent S&P Global Platts Analytics US CO2 Pricing Monitor, Biden is now targeting a carbon-free US power sector by 2035, as well as net-zero greenhouse gas (GHG) emissions by 2050.

In the event that Biden wins the election in November, his future administration can be expected to make considerable use of its executive and regulatory authority for energy and climate policymaking.

The Trump and Obama Administrations have previously done the same, and there are a number of key issues where Biden would be likely to act, including vehicle efficiency standards and methane limits for the oil and gas sector.

However, this would limit future policy efforts to the application of existing law, while more substantive policymaking would inevitably need to occur through legislation passed by Congress.

Go deeper: Request information about S&P Global Platts Analytics Future Energy Outlooks

While the Democrats recaptured the US House of Representatives in 2018 and are expected to maintain control

... continue reading 3rd party author's post at source website

order-1586392_1280

Can't Get Enough Freebies? Subscribe to our Newsletter!

We will send you free research and analysis summarized at the end of each month.

Leave a Comment

notes-150587_1280

More Articles.

ALLISON GATLIN

Moderna Stock Pops On Massive Sales Beat Despite Growing Losses

Moderna stock jumped in premarket action on Thursday even though the Covid-19 vaccine maker reported a bigger fourth-quarter loss than expected on Wednesday. But Moderna (MRNA) revenue was more than double what Wall Street forecast, due to rapidly growing vaccine manufacturing plans. X The biotech company lost 69 cents a share on sales of $570.7

Read More »

Get content like this sent directly to your inbox!

Follow OnceBurned

Share on facebook
Share on twitter
Share on linkedin
Scroll to Top